US Broker Ratings

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unveiling a 61.57% Upside Potential for Investors

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing investor attention in the biotechnology sector with its promising pipeline focused on precision oncology. As a clinical-stage company, Revolution Medicines is dedicated to..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 22% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is drawing significant attention from investors, thanks to its diversified portfolio in plasma therapeutics and a promising 22.46% potential..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Reveals 105% Upside Potential and Strong Buy Ratings

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is garnering substantial attention within the investment community. As a commercial-stage biopharmaceutical company, Telix is strategically positioned in the..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 60.96% Potential Upside

For investors exploring opportunities in the healthcare sector, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents a compelling case with its robust portfolio of diagnostic and therapeutic products. Based in Bedford, Massachusetts,..

Tempus AI, Inc. (TEM) Stock Analysis: Riding High on 89.6% Revenue Growth, But Is Valuation a Concern?

Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology company headquartered in Chicago, Illinois, has been making significant strides in the health information services industry. With a market capitalization of $15.92..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 25% Upside Potential Amidst Robust Pipeline Developments

For investors exploring the biotechnology sector, BridgeBio Pharma, Inc. (NASDAQ: BBIO) presents a compelling case. With a market capitalization of $10.11 billion, this company has carved out a niche in..

Exelixis, Inc. (EXEL) Stock Analysis: Unpacking Investor Ratings and a Promising 10.41% Upside

Exelixis, Inc. (EXEL), a prominent player in the biotechnology sector, continues to captivate investor interest with its focus on innovative cancer therapies. Operating within the healthcare industry, this United States-based..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Healthcare Giant Positioned for Modest Growth

Bausch + Lomb Corporation (NYSE: BLCO), a storied name in the healthcare sector, continues to draw investor interest as a key player in the medical instruments and supplies industry. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 149% Potential Upside in the Biotech Sector

Vaxcyte, Inc. (PCVX) is capturing the attention of investors with its significant potential upside of 149.26%, as indicated by analyst target prices. Operating within the healthcare sector and specializing in..

Waters Corporation (WAT) Stock Analysis: Navigating a 5.41% Potential Upside in the Healthcare Sector

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, stands as a significant entity for investors seeking exposure to analytical workflow..

Masimo Corporation (MASI) Stock Analysis: A 27% Upside Beckons in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a leader in the healthcare sector’s medical devices industry, presents a compelling case for investors seeking growth opportunities. With a market capitalization of $8 billion, Masimo..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 34% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector and medical devices industry, has captured the attention of investors with its significant growth potential. With a market..

Astrazeneca PLC (AZN)

⚠️ No article content returned.

..

Agilent Technologies, Inc. (A) Stock Analysis: A Closer Look at Its Potential Amidst a Modest Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, stands as a company of interest for investors seeking to navigate..

STERIS plc (STE) Stock Analysis: Evaluating a 12.32% Potential Upside in the Healthcare Sector

Investors with a keen eye on the healthcare sector should consider STERIS plc (STE), a prominent player in the medical devices industry with a diverse product offering. With a market..

Stryker Corporation (SYK) Stock Analysis: Navigating Growth and Potential 15.94% Upside

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, continues to capture investor attention with a market capitalization of $141.64 billion and a promising growth trajectory. Founded in..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 21.59% Potential Upside in Transforming Organ Transplants

TransMedics Group, Inc. (NASDAQ: TMDX) is capturing the attention of investors as it sits at the intersection of healthcare innovation and market opportunity. With a current market cap of $3.94..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a Potential 28.49% Upside

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, is capturing investor attention with its promising growth potential. Specializing in the development and marketing of medical devices,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Precision with a $27 Billion Market Cap

Mettler-Toledo International, Inc. (NYSE: MTD), a prominent player in the healthcare sector’s diagnostics and research industry, continues to draw investor attention with its robust market position and innovative product portfolio...

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with a 10.24% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the medical instruments and supplies industry, has been drawing attention from investors with its innovative solutions for the biopharma and healthcare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds